Macular Degeneration

The Pharmacy Times® Macular Degeneration Resource Center is a comprehensive resource for clinical news and expert insights on treatments for macular degeneration.

Latest News

Image credit: blackday | stock.adobe.com
FDA Approves Faricimab for Macular Edema Following Retinal Vein Occlusion

October 27th 2023

Faricimab is the first and only bispecific antibody granted FDA approval for treatment of the eye.

Credit:  ____ - stock.adobe.com
Aflibercept Biosimilar Demonstrates Equivalent Efficacy for Neovascular Age-Related Macular Degeneration

June 14th 2023

Credit: Dr_Microbe - stock.adobe.com
Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

May 3rd 2023

Eye Drops: Treatment Options and Infection Risks
Eye Drops: Treatment Options and Infection Risks

April 7th 2023

FDA Grants Priority Review to Aflibercept for Wet Age-Related Macular Degeneration
FDA Grants Priority Review to Aflibercept for Wet Age-Related Macular Degeneration

February 28th 2023

Latest CME Events & Activities

Addressing Unmet Needs and Treatment Gaps in the Clinical Management of Neovascular Age-Related Macular Degeneration: Practical Strategies for Pharmacists in Specialty and Man...

1.5 Credits / Ophthalmology/Optometry

View More

Management of Neuromyelitis Optica Spectrum Disorder: Expert Insights and Updates for Pharmacists, featuring a Patient Perspective

1.5 Credits / Ophthalmology/Optometry

View More

The Promising Role of Novel Targeted Therapies in Addressing Clinical and Economic Burdens in Diabetic Macular Edema

1.5 Credits / Ophthalmology/Optometry

View More

Geographic Atrophy: The Role of the Specialty Pharmacist in Introducing Disease-Specific Therapies

1.5 Credits / Ophthalmology/Optometry

View More

Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care

3.0 Credits / Ophthalmology/Optometry

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

AMD and DME: Addressing the Disease Burden, Treatment Challenges, and Opportunities for Improved Management

1.0 Credit / Ophthalmology/Optometry

View More

AMD and DME: Exploring New and Emerging Therapies in the Treatment Landscape

1.0 Credit / Ophthalmology/Optometry

View More

AMD and DME: Highlighting the Role of the Pharmacist in Patient Education and Counseling

1.0 Credit / Ophthalmology/Optometry

View More

Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars

1.0 Credit / Ophthalmology/Optometry

View More

Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacist Credit)

2.0 Credits / Ophthalmology/Optometry

View More

Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacy Technician Credit)

2.0 Credits / Ophthalmology/Optometry

View More

Assessing Utility of Anti-Vascular Endothelial Growth Factor Therapies in Retinal Disease: The Pharmacist’s Role From Access to Adherence, featuring a Patient Perspective

1.5 Credits / Ophthalmology/Optometry

View More

The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacy Technician Credit)

1.0 Credits / Ophthalmology/Optometry, Dermatology

View More

The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacist Credit)

1.0 Credits / Ophthalmology/Optometry, Dermatology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

© 2024 MJH Life Sciences

All rights reserved.